MUR
38
-6
ALLE
30
-7
SNA
53
-2
MAS
47
-4
EXC
47
-4
CI
50
-3
IP
65
-2
NVDA
59
5
IR
74
-5
ADT
50
-3
CHRW
48
3
XRAY
16
-3
VFC
57
-5
RF
45
-6
AMGN
52
-5
KIM
54
-6
TRV
42
-3
FRT
39
-7
CPB
35
-5
CAH
48
-5
MUR
38
-6
ALLE
30
-7
SNA
53
-2
MAS
47
-4
EXC
47
-4
CI
50
-3
IP
65
-2
NVDA
59
5
IR
74
-5
ADT
50
-3
CHRW
48
3
XRAY
16
-3
VFC
57
-5
RF
45
-6
AMGN
52
-5
KIM
54
-6
TRV
42
-3
FRT
39
-7
CPB
35
-5
CAH
48
-5
Financhill
Back

Intellia Therapeutics Vs. Keros Therapeutics Industry Stock Comparison

Sell
35

NTLA
Intellia Therapeutics

Last Price:
22.71
Seasonality Move:
7.84%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.53
Seasonality Move:
4.22%
Sell
35
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $23.98. The Score for NTLA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $23.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 48.45 Sell
Chaikin Money Flow: -1472603 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.73 - 25.43) Sell
Bollinger Bands (100): (22.8 - 28.38) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.8 Sell
20-day SMA: 23.73 Buy
50-day SMA: 23.58 Buy
200-day SMA: 27.43 Sell
8-day EMA: 24.46 Sell
20-day EMA: 24.27 Sell
50-day EMA: 24.41 Sell
200-day EMA: 28.49 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.00 per share, an increase this year of $0.28 per share, and a decrease next year of $0.38 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):